Trial Profile
Antibody response after vaccination with Japanese Hepatitis A Vaccine and evaluation of the booster program
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2020
Price :
$35
*
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary)
- Indications Hepatitis A
- Focus Pharmacodynamics
- 14 Dec 2020 Planned End Date changed from 31 Dec 2020 to 31 Jan 2021.
- 14 Dec 2020 Status changed from recruiting to active, no longer recruiting.
- 29 Jan 2019 Planned End Date changed from 31 Dec 2018 to 31 Dec 2020.